Background: Previous studies have shown beneficial effects of hepatocyte growth factor (HGF)
Introduction
Accurate assessment of regional and global left ventricular (LV) function by imaging is clinically important in ischemic heart disease. Ejection fraction (EF) and end-systolic volume are important predictors of survival and are used to manage therapy.(51) Echocardiography is the most widely used technique for non-invasive imaging of LV function because of its efficacy, relatively low cost, portability and widespread availability. The limitations of 2-dimensional echocardiography include the need for adequate acoustic windows, operator dependence and the use of geometric assumptions in computing LV volumes. Gated single photon emission computed tomography (SPECT) is also used for non-invasive imaging of regional and global LV function, but it has relatively low spatial and temporal resolution. Although echocardiography and SPECT are the most popular modalities for imaging the heart, magnetic resonance (MR) imaging is more sensitive for evaluation of LV function in patients and is used as a reference method. (2, 6, 17) Gene and stem cell therapy are under investigation as new therapies to prevent the deterioration of LV function after myocardial infarction. (36, 43) Hepatocyte growth factor (HGF) has been under investigation because of its combined angiogenic(29) and anti-fibrotic effects. (1, 47, 48) Several studies have recently shown the beneficial effects of HGF gene therapy in animal models of ischemic heart disease. (7, (19) (20) (21) 23 , 24, 42) The effect of different gene therapies on EF has been shown, but the mechanism for the increase in EF has not been defined. (10, 39, 44) Investigators have attributed the increase in regional function to: 1) compensatory hypertrophy of remote myocardium,(44) and 2) viable myocytes within the infarct. (13, 39) Left ventricular volumes, EF, regional wall thickness, systolic wall thickening (a measure of radial strain) and mass can be measured using cine MR imaging. Furthermore, tagging MR 4 imaging provides detailed information on circumferential and peak strain during the cardiac cycle. (11, 12, 25, 32, 33) Recently, a new plasmid (VM202) expressing two isoforms of HGF gene became available and was tested. (39) The effects of this novel therapy on regional LV function (systolic wall thickening-radial strain and circumferential strain) and global LV function (LV volumes, ejection fraction and mass) has not previously been determined using serial MR imaging.
Accordingly, we performed a non-invasive MR study to determine whether gene therapy expressing two isoforms of HGF gene could improve regional and global LV function in swine model of reperfused myocardial infarction. Histopathology was used to confirm the effects of therapy at the cellular level.
Methods

Animal Preparation
The study conformed to the Guide for the Care and Use of Laboratory Animals (NIH Publication No 85-23, revised 1996) and approval was obtained from the Institutional Committee on Animal
Research. Pigs (n=24, weight 30-40 kg) were premedicated by ketamine (20mg/kg, Ketaset; Fort Dodge Labs, Fort Dodge, Iowa), xylazinie (2mg/kg, Anased; Lloyd Labs, Shenandoah, Iowa) and atropine (0.04mg/kg, Phoenix Labs, St Joseph, Missouri), anesthesized using a mixture of 1.8-2.5% isoflurane (IsoFlo; Abbott Laboratories, North Chicago, Illinois) and oxygen, and intubated as previously described.(37) The animals (n=24) were divided into three groups. I: Controls without infarction (n=8). II Infarcted-controls (n=8) and III infarcted-treated with a gene expressing two isoforms of HGF (VM202) (n=8). After thoracotomy, the pericardium was opened and the left anterior descending (LAD) was identified and occluded for 2 hours distal to the first diagonal branch, followed by reperfusion. In group III, HGF gene (2 mg in 4 ml physiologic saline solution) was slowly injected into 4 periinfarction sites and 4 infarction sites as previously described.(39) The chest was closed layer by layer and the animals were allowed to recover for 3 days prior to the first imaging session. Four additional animals died during the LAD occlusion/reperfusion.
HGF-gene
VM202 (ViroMed, Co. Ltd, Seoul, Korea) was used for HGF-gene therapy. VM202 is a genomic-cDNA hybrid of human HGF gene, which expresses two isoforms of HGF, namely HGF and dHGF by way of alternative splicing. For construction of VM202, HGF-X7 was inserted into pCK DNA vector. The components of plasmid HGF gene (VM202) and their function have been described in earlier publications.(39, 41)
MR Imaging
A 1.5-T MR clinical scanner (Philips Medical Systems, The Netherlands) was used in all animals. Non-infarcted control animals were imaged once and infarcted animals twice, 3±0 days (acute phase) and 50±3 days (chronic phase) after the surgical procedure. In short, cine, tagging and delayed enhancement (DE) MR images were obtained of the left ventricle. (18) MR imaging protocols and parameters: After initial scout imaging to obtain the short-and long-axis imaging planes, an SSFP cine sequence was used to image the whole LV in the shortaxis view. Imaging parameters for the cine images were: TR/TE/flip angle = 3.5ms/1.75ms/70°, slice thickness=10mm, no slice gap, FOV=25x25 cm, matrix size=160x152, heart phases = 16.
Cine images were used for assessment of LV volumes, EF, wall thickness and thickening and LV mass. A tagged turbo-field echo planar (TF-EPI) sequence, obtained in the short-axis view covering the whole left ventricle, was used. Imaging parameters for the tagged cine images were: 6 TR/TE/flip angle = 35ms/6.1ms/25°, slice thickness=10mm, no slice gap, FOV=24x24 cm, matrix size=128x45, heart phases = 16, EPI factor = 11, tag technique = complementary spatial modulation of magnetization (CSPAMM) with vertical and horizontal tag orientation obtained in one breath hold, line spacing = 8 mm. Delayed enhancement (DE) MRI (IR-GRE) in the shortaxis view was used to locate and size the infarct so that functional assessment could be performed in infarcted, peri-infarcted and remote myocardium. DE-MRI was acquired 20min following 0.15 mmol/kg of Gd-DOTA administration (Guerbet Group, Paris, France). The imaging parameters were TR/TE/flip = 5ms/2ms/15 , slice thickness = 3mm, no slice gap, FOV=26x26cm, matrix size=256x162, the inversion time was chosen to null normal myocardium (270-325ms).
MRI Analysis. Global function was assessed as LV volumes, EF and LV mass by manual delineation of the endocardial and epicardial contours at end-systole and end-diastole in cine images, using the freely available software Segment v1.6(16) (http://segment.heiberg.se). LV volumes and mass were normalized to body weight in order to compare the results at the acute (32.3±0.5 kg) and chronic phase (48.4±1.4 kg).
Regional LV function was quantified in three consecutive apical, mid and basal short-axis slices through the infarcted myocardium using the centerline method. In each of these images a spokewheel was placed in the center of the cavity, dividing the myocardium into 8 regions starting with region 1 at the posteroseptal groove and continuing clockwise (Figure 1 ). Quantification of regional thickening was performed in 960 regions (8 per slice, 3 slices, 16 animals imaged twice and 8 animals imaged once). The peri-infarcted region was defined as 5 mm adjacent to the infarct in the anterior wall.
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Cine MR imaging were used to determine systolic and diastolic wall thickness. Regional systolic wall thickening was determined as (end-systolic wall thickness -end-diastolic wall thickness)/ end-diastolic wall thickness) *100. Tagged MR images in the same three short-axis planes as for wall thickening were used for strain analysis. Circumferential strain was calculated for all regions but only the remote, peri-infarct and infarcted regions are shown for clarity. Midwall eulerian circumferential shortening was measured using the HARP software (Diagnosoft Inc, Palo Alto, CA) (12, 32, 33) and peak circumferential strain was calculated. Peak strain values are negative during systole in normal myocardium because they express circumferential shortening.
Infarct transmurality was calculated as the percentage of hyperenhanced myocardium in eight segments each for the apical, mid and basal slices used for regional function analysis by Segment v1.6(9).
Postmortem Evaluation. The infarcted animals were euthanized after the second imaging session (50±3 days after infarction) and the hearts were excised. The LV was sliced into 10mm short-axis slices, weighed and stained by 2% triphenyltetrazolium chloride (TTC) for confirmation of infarction. Tissue samples were obtained from the infarcted, peri-infarcted and remote normal myocardium and embedded in paraffin, sliced (5µm) and stained with hematoxylin and eosin and Masson´s trichrome. Myocyte diameters were measured at 400x magnification using a calibrated reticule in the ocular of the microscope (Olympus, Japan). The myocyte diameters were measured at the nuclear level from transversely cut cells in islands/peninsulas of myocytes within the scar tissue, peri-infarcted and remote normal myocardium.
Statistical Analysis. Continuous variables are presented as mean±SEM. Wilcoxson matched
pairs test was used to compare LV volumes, LV ejection fraction and peak systolic strain at the 8 acute and chronic phase in the same group of animals. The Mann-Whitney test was used to compare LV volumes, LV ejection fraction and peak systolic strain between the groups. Twotailed unpaired Student's t-test was used to compare myocyte diameter and two-tailed paired Student's t-test within the groups. A value of p<0.05 was considered statistically significant.
Results
Global LV function on cine MR. EF in infarcted animals at 3 days did not differ between infarcted-treated (38±1%) and infarcted-control animals (41±1, p=0.13), (Figure 2 ). Both groups had significantly lower EF compared to controls without infarction (52±1%, p<0.001 compared to both groups). However, at 50±3 days after infarction the EF of infarcted-treated animals had increased to 47±2% (p<0.01 compared to 3 days and p=0.16 compared to controls without infarction) and decreased to 37±1% in the infarcted-controls (p<0.05 compared to 3 days). At 50 days, the EF of infarcted-treated animals was markedly higher than in infarcted-controls (47±2% vs. 37±1%, p<0.001). The increase in EF in infarcted-treated animals over time was associated with a decrease in EDV (2.15±0.10 vs. 1.73±0.10 ml/kg, p<0.05) and ESV (1.33±0.07 vs. Regional LV function on tagging MR. Circumferential strain differed between the groups throughout the cardiac cycle as demonstrated in Figure 6 . The peak strain of the remote, periinfarct and infarcted regions for the basal, mid and apical slices for all animals are shown in Figure 7 . At 3 days, peak strain was not significantly different between controls without infarction and infarcted-controls and infarcted-treated animals in remote myocardium. On the other hand, peak strain was significantly lower in the peri-infarcted (p<0.01) and infarcted (p<0.01) regions in both infarcted-treated and infarcted-controls compared to controls without infarction. At 50 days, peak strain was still significantly lower in peri-infarcted and infarcted regions (p<0.001) in infarcted-controls compared to controls without infarction. A small, but significant, increase in peak strain could be seen in the infarcted regions in infarcted-controls (p<0.05). However, the increase in peak strain was more pronounced in peri-infarcted (p<0.05) and infarcted regions (p<0.001) in infarcted-treated animals. Moreover, the peak strain in the infarcted region of treated animals occured late in the cardiac cycle compared to normal animals.
Unlike infarcted-control animals, there was a significant increase (p<0.01) in peak systolic strain in basal and apical slices of remote myocardium at 50 days, in infarcted-treated animals.
Infarct evolution. Multislice MR images from infarcted-control and infarcted-treated animals are shown in Figure 8 . The infarcts were seen as hyperenhanced regions in the LV anteroseptal wall in all animals. As previously reported, (39) the decrease in infarct size was greater in the infarcted-treated animals compared to infarcted-controls. At 50 days, the infarct decreased in both infarcted-treated (16.5±1.8% to 7.0±0.5% of LV mass, p<0.05) and infarcted-control animals (16.6±1.1% to 13.2±1.6% LV mass, p<0.05), but to a greater extent in treated animals, p<0.05. The transmurality of the infarction in the three slices used for cine and tagging analysis are shown in Figure 9 . Over time transmurality of the infarction decreased in both groups, however the decrease was greater in the infarcted-treated animals. Also, an endocardial rim of viable tissue was seen in the basal part of the infarct (Figure 9 ).
Histopathology
Histochemical TTC and histological staining confirmed the formation of infarction and scar tissue in animals that underwent occlusion of the LAD. Myocardial TTC sections confirmed the lower transmurality of the infarction seen on MR-imaging in infarcted-treated animals compared to infarcted-controls (Figure 10 ). In infarcted-treated animals, viable myocardium was interspersed with infarcted tissue and in the basal slice of the infarction an endocardial rim of viable myocardium could be seen both on MR and TTC images. There was a high correlation between quantification of infarct size with MR and TTC (r=0.92, y=0.94x+1.3, P<0.001, Figure   3 ).
Histopathology showed that the myocyte diameter was significantly smaller in the peri-infarcted (21±1µm) and remote myocardium (19±1µm) of infarcted-treated animals compared with infarcted-controls (26±1µm and 25±1µm respectively; p<0.001 for both), (Figure 10 ). In infarcted-treated animals peninsulas and islands/peninsulas of viable myocytes were present within the infarct (Figure 10 ). The diameter of these myocytes was 29±1µm, significantly larger than peri-infarcted and remote myocardium of the infarcted-treated animals (p<0.001 for both).
Discussion
The main findings are that: 1 ) intramyocardially transferred plasmid HGF-gene (VM202) caused near complete recovery of EF within 50 days of infarction, 2) the therapy prevented LV remodeling associated with infarction, 3) the improvement in regional and global function in treated animals is most likely attributed to the speedy and significant resorption of infarction and island/peninsulas of hypertrophied myocytes within the infarcted territory, 4) treated animals showed no evidence of compensatory hypertrophy in remote myocardium as shown in cine MR measurement of LV mass, wall thickness or microscopic measurement of myocyte diameter compared to infracted-control animals and 5) the complimentary use of cine and tagging MR imaging provides valuable information on the efficacy of gene therapy in ischemic heart disease, thus it can be used for non-invasive assessment of gene or cell therapy.
The importance of circumferential strain and systolic wall thickening (radial strain), using In the current study, the HGF gene caused significant reduction in infarct size and transmurality. Furthermore, the function of remote myocardium in the lateral wall is higher in the infarctedtreated animal compared to infarcted-control. ED end-diastole, ES end-systole. 
